Search results
Results From The WOW.Com Content Network
By Sriparna Roy. (Reuters) -Boston Scientific will buy Silk Road Medical in a $1.16 billion deal, the company said on Tuesday, adding medical devices used for stroke prevention. Boston, which ...
Boston Scientific: Guidant: 24.6 38 With the lower re-negotiated a lower price of $21.5 billion between Johnson & Johnson and Guidant, Boston Scientific announced an unsolicited offer of $24.6 billion for Guidant (an offer of $72 per share of Guidant, $36 in cash and a fixed number of Boston Scientific shares valued at $36 a share). 26 2006
Net income. £6.2 million (2007) [1] Number of employees. 89 (2007) [1] Website. www.biocompatibles.com. Biocompatibles International plc was a medical technology company in the field of drug-device combination products. It was acquired by BTG plc in 2010, [2] which was, in turn, acquired by Boston Scientific in 2019. [3] [4]
It specializes in private equity, venture capital, credit, public equity, impact investing, life sciences, crypto, tech opportunities, partnership opportunities, special situations, and real estate. Bain Capital invests across a range of industry sectors and geographic regions. [ 3] The firm was founded in 1984 by partners from the consulting ...
For premium support please call: 800-290-4726 more ways to reach us
Today, Boston Scientific is valued at around $110 billion and "treats" over 75 patients globally every minute through its assortment of medical devices such ad pacemakers, catheters, stents, and ...
Boston Scientific was formed June 29, 1979, in Watertown, Massachusetts, as a holding company for the medical products company, Medi-Tech, Inc., and to position the company for growth in interventional medicine. [ 6] Medi-Tech was the brainchild of Itzhak Bentov, a Czech-born émigré to Israel and then to the United States, who worked at the ...
Boston Scientific's revenue peaked in 2007 at $8.4 billion. Last year, the comparable number was $7.2 billion. In 2012, Boston Scientific lost more than $4 billion, much of it due to special charges.